Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

After US Request, China Bans Four Synthetic Opioids

publication date: Jun 19, 2017
As part of an ongoing collaboration with the US, China agreed to ban the manufacture of four synthetic opioids, each a variation of fentanyl. China is thought to be a major source of the so-called "designer drugs," which have been implicated in an increasing number of fatal overdoses in the US. The most widely used drug of the four is U-47700, a drug that was found at the house of entertainer Prince following his overdose last year. In March, China banned another four fentanyl alternatives, including carfentanil, a fentanyl-type drug used on large animals such as rhinos. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital